INVO FertilityIVF -2.59%35 1-Year ROIIC % is -0.79 as of Mar. 2026. GuruFocus rates IVF with a GF Score™ of 35/100 and a GF Value™ of $134.71 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 824 Medical Devices & Instruments companies, INVO Fertility ranks worse than 51.82% on this metric.
1-Year Return on Invested Incremental Capital (1-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 1-year.
INVO Fertility's 1-Year ROIIC % for the quarter that ended in Mar. 2026 was -0.79%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for INVO Fertility's 1-Year ROIIC % or its related term are showing as below:
IVF's 1-Year ROIIC % is ranked worse than 51.82% of 824
companies
in the Medical Devices & Instruments industry
Industry Median: 0.38
vs IVF: -0.79
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
INVO Fertility 1-Year ROIIC % Related Terms
INVO Fertility 1-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for INVO Fertility's 1-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IVF vs RMSL, ADMT, USAQ: 1-Year ROIIC % Comparison
For the Medical Devices subindustry, INVO Fertility's 1-Year ROIIC %, along with its competitors' market caps and 1-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
INVO Fertility 1-Year ROIIC % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, INVO Fertility's 1-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where INVO Fertility's 1-Year ROIIC % falls into.
INVO Fertility's 1-Year ROIIC % for the quarter that ended in Mar. 2026 is calculated as:
1-Year ROIIC %
=
1-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
1-Year Incremental Invested Capital
=
( -6.231 (Mar. 2026) - -6.369 (Mar. 2025) )
/
( 21.56 (Mar. 2026) - 39.109 (Mar. 2025) )
=
0.138
/
-17.549
=
-0.79%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** TTM data of NOPAT and Invested Capital was used to calculate 1-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
INVO Fertility (IVF) has a 1-Year ROIIC % of -0.79 as of Mar. 2026. 1-Year ROIIC % measures the change in earnings as a percentage of change in investment over 1-year. View historical data on INVO Fertility and its competitors. According to the industry distribution chart, INVO Fertility ranks #427 out of 824 companies in the Medical Devices & Instruments industry, placing it in the top 51.8%.
Is INVO Fertility's 1-Year ROIIC % too high?
INVO Fertility's current 1-Year ROIIC % is -0.79. Based on the distribution chart, INVO Fertility ranks #427 out of 824 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, INVO Fertility has a GF Score™ of 35/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does INVO Fertility's 1-Year ROIIC % compare to RMSL and ADMT?
According to the Medical Devices & Instruments industry distribution chart, INVO Fertility ranks #427 out of 824 companies for 1-Year ROIIC %. This places INVO Fertility in the lower half of its industry. The industry median 1-Year ROIIC % is 0.38. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 1-Year ROIIC % for a Medical Devices & Instruments company?
The median 1-Year ROIIC % among Medical Devices & Instruments companies is 0.38, based on 824 companies in the industry. Companies in the top quartile (top 25%) have a 1-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 1-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 1-Year ROIIC % mean?
A high 1-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 1-Year ROIIC % measures the change in earnings as a percentage of change in investment over 1-year. View historical data on INVO Fertility and its competitors. For the Medical Devices & Instruments industry, the median 1-Year ROIIC % is 0.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. INVO Fertility's current 1-Year ROIIC % is -0.79. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is INVO Fertility stock overvalued right now?
Based on GuruFocus' analysis, INVO Fertility (IVF) is currently considered Possible Value Trap. The stock's GF Value™ is $134.71, compared to a current price of $1.13 — trading 99.2% below its estimated fair value. The current 1-Year ROIIC % is -0.79. INVO Fertility's overall GF Score™ is 35/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 1-Year ROIIC % calculated?
1-Year ROIIC % is calculated from a company's financial statements. For INVO Fertility (IVF), the current 1-Year ROIIC % is -0.79 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is INVO Fertility (IVF) Overvalued in 2026?
Based on GuruFocus' analysis, INVO Fertility stock appears to be undervalued.
The current stock price of $1.13 is trading 99.2% below its estimated GF Value™ of $134.71.
GuruFocus considers INVO Fertility to be Possible Value Trap.
Key valuation signals for IVF:
1-Year ROIIC %: -0.79
GF Value™: $134.71 vs. price of $1.13 (99.2% below fair value)
No single metric tells the full story. See the IVF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
INVO Fertility Inc is a healthcare services fertility company dedicated to expanding assisted reproductive technology (ART) care to patients in need. It is offering the intravaginal culture (IVC) procedure enabled by INVOcell medical device (INVOcell). The INVOcell is a proprietary and revolutionary medical device, and the first to allow fertilization and early embryo development to take place in vivo within the woman's body. The company's segments include: The Clinics Services operating segment consisting of financial information for WFI and the Atlanta Clinic and The INVOcell Device operating segment consisting of financial information relating to the manufacture and sales of the INVOcell.
35GF Score
Get the complete analysis for IVF
1-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IVF has been successfully added to your 
